Cover Image
市場調查報告書

Antoxis Limited的產品平台分析

Antoxis Limited - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293980
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Antoxis Limited的產品平台分析 Antoxis Limited - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 21 Pages
簡介

Antoxis Limited是總公司設立於英國的藥物研發企業,開發·提供氧化壓力和粒腺體障礙等病理治療技術。該公司的Kromex化學平台,可解決治療中發生的氧化壓力及缺乏抗氧化物質之平台。同時也開發分化等細胞過程低分子。

本報告提供Antoxis Limited 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Antoxis Limited 基本資料

  • Antoxis Limited 概要
  • 主要資訊
  • 企業資料

Antoxis Limited :R&D概要

  • 主要的治療範圍

Antoxis Limited :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Antoxis Limited :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Antoxis Limited :藥物簡介

  • Anto-028
  • AO-1530
  • AO-2012
  • AO-OMe
  • Small Molecules for Cancer

Antoxis Limited :開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Antoxis Limited :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06880CDB

Global Markets Direct's, 'Antoxis Limited - Product Pipeline Review - 2015', provides an overview of the Antoxis Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Antoxis Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Antoxis Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Antoxis Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Antoxis Limited's pipeline products

Reasons to buy

  • Evaluate Antoxis Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Antoxis Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Antoxis Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Antoxis Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Antoxis Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Antoxis Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Antoxis Limited Snapshot
    • Antoxis Limited Overview
    • Key Information
    • Key Facts
  • Antoxis Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Antoxis Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Antoxis Limited - Pipeline Products Glance
    • Antoxis Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Antoxis Limited - Drug Profiles
    • Anto-028
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AO-1530
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AO-2012
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AO-OMe
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Antoxis Limited - Pipeline Analysis
  • Antoxis Limited - Pipeline Products by Target
  • Antoxis Limited - Pipeline Products by Molecule Type
  • Antoxis Limited - Pipeline Products by Mechanism of Action
  • Antoxis Limited - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Antoxis Limited, Key Information
  • Antoxis Limited, Key Facts
  • Antoxis Limited - Pipeline by Indication, 2015
  • Antoxis Limited - Pipeline by Stage of Development, 2015
  • Antoxis Limited - Monotherapy Products in Pipeline, 2015
  • Antoxis Limited - Preclinical, 2015
  • Antoxis Limited - Discovery, 2015
  • Antoxis Limited - Pipeline by Target, 2015
  • Antoxis Limited - Pipeline by Molecule Type, 2015
  • Antoxis Limited - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Antoxis Limited - Pipeline by Top 10 Indication, 2015
  • Antoxis Limited - Pipeline by Stage of Development, 2015
  • Antoxis Limited - Monotherapy Products in Pipeline, 2015
  • Antoxis Limited - Pipeline by Top 10 Target, 2015
  • Antoxis Limited - Pipeline by Top 10 Molecule Type, 2015
  • Antoxis Limited - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top